CLINICAL EFFECTS OF TRAMIPROSATE IN APOE4/4 HOMOZYGOUS PATIENTS WITH MILD ALZHEIMER’S DISEASE SUGGEST DISEASE MODIFICATION POTENTIAL | Center for Neurodegeneration and Translational Neuroscience (CNTN)

Abushakra S, Porsteinsson A, Scheltens P, Sadowsky C, Vellas B, Cummings J

Hournal Prev Alzheimer’s Dis

January 2017

← Back to Publications